<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A flow cytometric approach to <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>) monitoring useful in childhood B-lineage <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> (ALL) is discussed here in the context of ALL in adults </plain></SENT>
<SENT sid="1" pm="."><plain>Of 64 <z:hpo ids='HP_0001909'>leukemia</z:hpo> samples analyzed, 95.3% had at least one abnormal phenotype (57.3% had two or more) as compared to physiologic B-cell precursors in adult bone marrow </plain></SENT>
<SENT sid="2" pm="."><plain>The method was sensitive enough to detect one leukemic cell among 10,000 <z:mpath ids='MPATH_458'>normal</z:mpath> cells in 16/19 experiments (84.2%) </plain></SENT>
<SENT sid="3" pm="."><plain>Blast phenotypes were stable in culture and at relapse, and were useful for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> monitoring in patients </plain></SENT>
<SENT sid="4" pm="."><plain>Marker combinations for <z:e sem="disease" ids="C0023452" disease_type="Neoplastic Process" abbrv="">childhood ALL</z:e> are also applicable to adult cases </plain></SENT>
</text></document>